Jason Ehrlich - 16 Feb 2022 Form 4 Insider Report for Kodiak Sciences Inc. (KOD)

Reporting relationship: Chief Medical Officer and Chief Development Officer
Issuer ticker: KOD
Reported as of: 16 Feb 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 18 Feb 2022, 16:14:48 UTC
Prior SEC filing: 24 Jan 2022
Next SEC filing: 14 Jun 2022
Source filing: View source filing
Reporting owner signature: /s/ David Peinsipp, Attorney-in-Fact for Jason Ehrlich

Key filing fact

Jason Ehrlich filed Form 4 for Kodiak Sciences Inc. (KOD) on 18 Feb 2022.

Key facts

This page summarizes Jason Ehrlich's Form 4 filing for Kodiak Sciences Inc. (KOD).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 18 Feb 2022, 16:14.

Change

Previous filing in this sequence was filed on 24 Jan 2022.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

KOD transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +15,000
Change %
Price: $0.000000
Shares after: 15,000
Date: 16 Feb 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 15,000
Exercise price: $131.44
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

On February 21, 2021, the Reporting Person was awarded a performance-based option. 1/4th of the shares subject to the option vested on February 16, 2022 upon the achievement of certain performance criteria (the "Performance Criteria Achievement Date"); thereafter, the shares subject to the option will vest in thirty-six (36) successive equal monthly installments measured from the Performance Criteria Achievement Date, subject, in each case, to the Reporting Person's status as a Service Provider (as defined in the 2018 Equity Incentive Plan) on each vesting date.

SEC remarks

Chief Medical Officer and Chief Development Officer